JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nader, N. D.
Right arrow Articles by Steinhorn, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nader, N. D.
Right arrow Articles by Steinhorn, D. M.
Anesth Analg 2000;90:356
© 2000 International Anesthesia Research Society


CRITICAL CARE AND TRAUMA

Systemic Perfluorocarbons Suppress the Acute Lung Inflammation After Gastric Acid Aspiration in Rats

Nader D. Nader, MD, PhD*, Paul R. Knight, MD, PhD{dagger}, Bruce A. Davidson, BS{dagger}, Saeid S. Safaee, MD{ddagger}, and David M. Steinhorn, MD§

*Department of Anesthesiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas; {dagger}Department of Anesthesiology, SUNY at Buffalo, Buffalo, New York; {ddagger}Polyclinic Hospital, Harrisburg, Pennsylvania; and §Northwestern University, Chicago, Illinois

Address correspondence and reprint requests to Nader D. Nader, MD, PhD, Chief, Anesthesiology Service (110/LR), Central Arkansas VA Healthcare System, 4300 7th St., Little Rock, AR 72205. Address e-mail to: nnader{at}med.va.gov

Perflurocarbons (PFCs) are used during liquid ventilation and as hemoglobin substitutes. PFCs reduce free radical generation and damage to the lung during liquid ventilation. Thus, we examined the effects of parenteral administration of PFCs on lung injury after acid aspiration. Rats were treated with intraperitoneal injection of either FC-77 or IV injection of Fluosol. Controls received intraperitoneal or IV normal saline (NS) before or at the time of injury and then were injured by instillation of NS + HCl (pH = 1.25) into their lungs via a tracheotomy. The animals were exposed to air or 98% oxygen, breathing spontaneously. The rats were injected with 0.05 µCi of 125I-albumin (bovine serum albumin) before injury. The extent of lung injury was assessed 5 h postinjury by compliance and lung albumin permeability index measurement. Myeloperoxidase (MPO) activity and histologic examination were used to assess neutrophilic infiltration. Both FC-77 and Fluosol decreased the permeability index compared with controls (1.05 ± 0.08; 1.08 ± 0.12, respectively, versus 1.34 ± 0.21) and improved lung compliance after intratracheal instillation of 1.2 mL/kg of HCl/NS, pH = 1.25 + hyperoxia injury (P < 0.05). Lung MPO activity decreased in the FC-77 group and was associated with a concomitant decrease in neutrophil infiltration. MPO activity of the spleen increased after FC-77 treatment. The administration of FC-77 decreased the severity of lung permeability changes associated with acid in the presence or absence of hyperoxia exposure. These data suggest that attenuation of neutrophilic infiltration by PFCs decreases lung injury.

Implications: Intraperitoneally administered perfluorocarbons in rats attenuate the neutrophilic infiltration in the lung after acid aspiration, thereby decreasing the alveolar protein leakage and improving pulmonary compliance.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. H. Segal, B. A. Davidson, A. D. Hutson, T. A. Russo, B. A. Holm, B. Mullan, M. Habitzruther, S. M. Holland, and P. R. Knight III
Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L760 - L768.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. F. Isik, I. Kati, I. Bayram, and H. Ozbek
A new agent for treatment of acute respiratory distress syndrome: thymoquinone. An experimental study in a rat model
Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 301 - 305.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. von der Hardt, M. A. Kandler, L. Fink, E. Schoof, J. Dotsch, R. M. Bohle, and W. Rascher
Laser-assisted microdissection and real-time PCR detect anti-inflammatory effect of perfluorocarbon
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L55 - L62.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.